M.LiuJ.BielefeldE
The anthocyanin delphinidin 3-rutinoside stimulates glucagon-like peptide-1 secretion in murine GLUTag cell line via the Ca 2+ /calmodulin-dependent kinase II pathway
A growing number of evidence indicates that GLP-1-based therapies have anti-inflammatory effects in various cells, tissues, and organs by reducing the synthesis of pro-inflammatory cytokines and limiting immune cell infiltration
Your prescription ships discreetly with supplies
GLP-1 drugs stimulate the release of insulin when blood sugar is elevated, inhibit the release of glucagon (a hormone that raises glucose), and slow stomach emptying, helping people feel fuller for longer
Oral administration to diet-induced-obese mice for ~10 days reduces fat mass without altering food intake, decreases adipocyte size, restores insulin sensitivity, and increases adipose NAD and SAM levels [2]